Advances in Pulmonary Embolism Biomarkers
DOI:
https://doi.org/10.53469/jcmp.2024.06(09).07Keywords:
Pulmonary embolism, BiomarkersAbstract
Pulmonary embolism is the third leading cause of death in cardiovascular disease worldwide, after myocardial infarction and stroke. Traditionally, pulmonary angiography has been considered the gold standard for diagnosing pulmonary embolism. However, with advancements in medical care, less invasive tests such as computed tomography pulmonary arteriography (CTPA) and ventilation/perfusion imaging (V/Q imaging) have emerged, which, while less invasive than traditional angiography, are still complex and carry various risks. Various biomarkers identified to date have demonstrated reliability in the diagnosis, stratification, and prognosis of pulmonary embolism. Therefore, this paper aims to summarize the relevant biomarkers of pulmonary embolism and provide a basis for improving early diagnosis and treatment.
References
KAHN S R, DE WIT K. Pulmonary Embolism [J]. The New England Journal of Medicine, 2022, 387(1): 45-57.
CHRYSIKOS S, PAPAIOANNOU O, KARAMPITSAKOS T, et al. Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary Embolism [J]. Advances in Respiratory Medicine, 2022, 90(4): 300-309.
DUFFETT L, CASTELLUCCI L A, FORGIE M A. Pulmonary embolism: update on management and controversies [J]. BMJ, 2020: m2177.
KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) [J]. European Heart Journal, 2020, 41(4): 543-603.
LINKINS L A, TAKACH LAPNER S. Review of D-dimer testing: Good, Bad, and Ugly [J]. International Journal of Laboratory Hematology, 2017, 39 Suppl 1: 98-103.
COSMI B, LEGNANI C, LIBRA A, et al. D-Dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications [J]. Polish Archives of Internal Medicine, 2023, 133(11): 16604.
KEARON C, DE WIT K, PARPIA S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability [J]. The New England Journal of Medicine, 2019, 381(22): 2125-2134.
JANISSET L, CASTAN M, POENOU G, et al. Cardiac Biomarkers in Patients with Acute Pulmonary Embolism [J]. Medicina (Kaunas, Lithuania), 2022, 58(4): 541.
BI W, LIANG S, HE Z, et al. The Prognostic Value of the Serum Levels of Brain Natriuretic Peptide, Troponin I, and D-Dimer, in Addition to the Neutrophil-to-Lymphocyte Ratio, for the Disease Evaluation of Patients with Acute Pulmonary Embolism [J]. International Journal of General Medicine, 2021, 14: 303-308.
C B, G M, DR V, et al. Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis [J]. European heart journal, 2021, 42(33).
E S H, M W J, LE B, et al. Troponin dependent 30-day mortality in patients with acute pulmonary embolism [J]. Journal of thrombosis and thrombolysis, 2023, 56(3).
MOON M G, YOON C H, LEE K, et al. Evaluation of Heart-type Fatty Acid-binding Protein in Early Diagnosis of Acute Myocardial Infarction [J]. Journal of Korean Medical Science, 2021, 36(8): e61.
GOEL H, MELOT J, KRINOCK M D, et al. Heart-type fatty acid-binding protein: an overlooked cardiac biomarker [J]. Annals of Medicine, 2020, 52(8): 444-461.
UNAL E, AKOGLU H, SANRI E, et al. The utility of heart-type free fatty-acid binding-protein (HFABP) levels for differentiating acute ischemic stroke from stroke mimics [J]. Acta Neurologica Belgica, 2024, 124(1): 183-191.
SUN J H, LIU X K, XING X W, et al. Value of Cardiac Troponin, Myoglobin Combined with Heart-type Fatty Acid-binding Protein Detection in Diagnosis of Early Acute Myocardial Infarction [J]. Pakistan Journal of Medical Sciences, 2023, 39(6): 1690-1694.
MIRNA M, ROHM I, JIRAK P, et al. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH) [J]. Heart, Lung & Circulation, 2020, 29(3): 337-344.
LIU M, YUAN X, QIU X, et al. Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: a meta-analysis [J]. Thrombosis Research, 2015, 135(1): 20-25.
QIAN H Y, HUANG J, YANG Y J, et al. Heart-type Fatty Acid Binding Protein in the Assessment of Acute Pulmonary Embolism [J]. The American Journal of the Medical Sciences, 2016, 352(6): 557-562.
JENAB Y, POURJAFARI M, SOTOUDEH M, et al. Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism [J]. Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace, 2017, 87(1): 767.
SAGCAN G, DOGAN Z, UZUN H, et al. Impact of Promising Biomarkers on Severity and Outcome of Acute Pulmonary Embolism [J]. International Journal of General Medicine, 2023, 16: 3301-3309.
KOKALJ N, KOZAK M, JUG B. Post-acute pre-discharge echocardiography in the long-term prognostic assessment of pulmonary thrombembolism [J]. Scientific Reports, 2021, 11(1): 1-7.
PHAN T, BRAILOVSKY Y, FAREED J, et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism [J]. Clinical and Applied Thrombosis/ Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/ Hemostasis, 2020, 26: 1076029619900549.
ALSUBHI Y M, ALHADI A H, HAMMUDAH A M, et al. Comparison of laboratory biomarkers for the prediction of in-hospital mortality and severity of acute pulmonary embolism: A multi-center study [J]. Saudi Medical Journal, 2023, 44(9): 898-903.
HAMMONS L, FILOPEI J, STEIGER D, et al. A narrative review of red blood cell distribution width as a marker for pulmonary embolism [J]. Journal of Thrombosis and Thrombolysis, 2019, 48(4): 638-647.
ALLEN L A, FELKER G M, MEHRA M R, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure [J]. Journal of Cardiac Failure, 2010, 16(3): 230-238.
INUZUKA R, ABE J. Red blood cell distribution width as a link between ineffective erythropoiesis and chronic inflammation in heart failure [J]. Circulation Journal: Official Journal of the Japanese Circulation Society, 2015, 79(5): 974-975.
BABAOGLU E, ULASLI S S. Clinical importance of red cell distribution width and red cell index in pulmonary embolism [J]. European Review for Medical and Pharmacological Sciences, 2023, 27(9): 4108-4115.
LIAO Y, YANG C, BAKEER B. Prognostic value of red blood cell distribution width in patients with acute pulmonary embolism: A protocol for systematic review and meta-analysis [J]. Medicine, 2021, 100(18): e25571.
YAZICI S, KIRIŞ T, SADIK CEYLAN U, et al. Relation between dynamic change of red cell distribution width and 30-day mortality in patients with acute pulmonary embolism [J]. The Clinical Respiratory Journal, 2018, 12(3): 953-960.
BÜYÜKŞIRIN M, ANAR C, POLAT G, et al. Can the Level of CRP in Acute Pulmonary Embolism Determine Early Mortality? [J]. Turkish Thoracic Journal, 2021, 22(1): 4-10.
HALICI B, SARINC ULASLI S, GÜNAY E, et al. Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results [J]. Inflammation, 2014, 37(4): 1186-1190.
USLU M F, YILMAZ M, ATEŞÇELIK M, et al. The utility of the systemic immune inflammation and systemic inflammation response indices in suspected intermediate-risk pulmonary embolism [J]. Croatian Medical Journal, 2024, 65(1): 13-19.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yihan Chen, Yating Duan, Yali Qi
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
